Efficacy and Safety of Rituximab in Connective Tissue Disease related Interstitial Lung Disease.

Abstract

Treatment with RTX resulted in an objective, measurable improvement in pulmonary function and/or radiological severity for the majority of patients included in the series. This was statistically significant despite the small numbers included. These results indicate a positive response to RTX with few complications of treatment.